Results 11 to 20 of about 3,661,902 (238)

Tocolytic agents and the failure to improve neonatal outcomes

open access: yesPregnancy
Premature delivery has long been a major problem in obstetrics. Increased perinatal morbidity and mortality as well as substantial health care costs, both short and long term, have driven the efforts to combat this complication.
Jack FitzSimmons, Emily Oliver
doaj   +3 more sources

Effects of sympathomimetic tocolytic agents on the fetus [PDF]

open access: yesJournal of Perinatal Medicine, 1974
The variety of factors controlling the onset of parturition, as well as the very complex mechanisms which physiologically maintain pregnancy by inhibiting uterine contractions are only partially understood today. As long as the triggering mechanisms, and the conditions favoring timely and early labor are incompletely known, symptomatic therapeutic ...
V. Unbehaun
openaire   +3 more sources

Preventing Preterm Birth: The Search for Tocolytic Synergism. [PDF]

open access: yesReprod Sci
Preterm birth is a common cause of neonatal mortality and morbidity, which are increasingly prevalent today. Preterm birth affects millions of babies worldwide and is the subject of intense study in its pathophysiology and therapy.
Hossain MR   +4 more
europepmc   +2 more sources

Assessing Tocolytic Potency: Variability and Accuracy of AUC Versus Amplitude-Based Assessment of Pregnant Human Myometrial Contractions Ex Vivo. [PDF]

open access: yesReprod Sci
The methodological approaches used to evaluate the inhibitory effects (potency determination) of tocolytic agents on human uterine contractions in ex vivo systems vary, and none of the methodologies has been subjected to scrutiny in terms of objectivity,
Hossain MR   +4 more
europepmc   +2 more sources

Evaluation of the effects of indomethacin tocolytic treatment on fetal heart using modified myocardial performance index (Mod-MPI) [PDF]

open access: yesBMC Pregnancy and Childbirth
Background Indomethacin is one of the most effective and widely used tocolytic agents for treating threatened preterm labor and prolonging pregnancy. Nonetheless, data on its fetal effects, particularly regarding cardiac functions, remain limited.
Barış Boza, Fırat Ersan, Verda Alpay
doaj   +2 more sources

Gauging the safety and efficacy of nitroglycerine used transdermally as a tocolytic agent in females with preterm labor

open access: yesMuller Journal of Medical Sciences and Research
Background: Preterm labor is the primary challenge in prenatal health care, leading to a high rate of mortality. As a result, in pregnant women with preterm labor, we use nitroglycerine transdermally as a tocolytic agent. The main objective of this study
Anand Tambat   +2 more
doaj   +2 more sources

A historical narrative review through the field of tocolysis in threatened preterm birth [PDF]

open access: yesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology: X
Preterm birth presents a significant challenge in clinical obstetrics, requiring effective strategies to reduce associated mortality and morbidity risks.
Tijn van Winden   +4 more
doaj   +2 more sources

Comparative effectiveness and safety of nifedipine and magnesium sulfate as treatment options for preterm birth: a systematic review and meta-analysis [PDF]

open access: yesBMJ Open
Objectives Preterm birth (PTB) is a major cause of neonatal morbidity and mortality worldwide. Effective use of tocolytic agents may improve perinatal outcomes.
Jie Chen   +7 more
doaj   +2 more sources

Synergistic effects of nifedipine and indomethacin in tocolysis: A translational study. [PDF]

open access: yesInt J Gynaecol Obstet
International Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1418-1420, December 2025.
Yart L, Cohen M, Martinez de Tejada B.
europepmc   +2 more sources

School Performance After Maintenance Tocolysis With Nifedipine for Threatened Preterm Birth: 12-Year Follow-Up of the APOSTEL 2 Trial. [PDF]

open access: yesBJOG
ABSTRACT Objective To evaluate school performance at 12 years of age in children prenatally exposed to maintenance tocolysis with nifedipine versus placebo. Design 12‐year follow‐up of the multicentre APOSTEL 2 trial, in which participants with threatened preterm birth between 26+0 and 32+2 weeks of gestation, who remained pregnant after initial 48‐h ...
van der Windt LI   +8 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy